Venkateshwar Madka to Animals
This is a "connection" page, showing publications Venkateshwar Madka has written about Animals.
Connection Strength
0.687
-
Chromatin Remodulator CHD4: A Potential Target for Cancer Interception. Genes (Basel). 2025 Feb 15; 16(2).
Score: 0.093
-
Stat3 Inhibitors TTI-101 and SH5-07 Suppress Bladder Cancer Cell Survival in 3D Tumor Models. Cells. 2024 Aug 31; 13(17).
Score: 0.090
-
Proton Pump Inhibitor Omeprazole Suppresses Carcinogen-induced Colonic Adenoma Progression to Adenocarcinoma in F344 Rat. Cancer Prev Res (Phila). 2021 11; 14(11):1009-1020.
Score: 0.073
-
Bisphosphonates Zometa and Fosamax Synergize with Metformin to Prevent AOM-Induced Colon Cancer in F344 Rat Model. Cancer Prev Res (Phila). 2020 02; 13(2):185-194.
Score: 0.065
-
Targeting mTOR and p53 Signaling Inhibits Muscle Invasive Bladder Cancer In Vivo. Cancer Prev Res (Phila). 2016 Jan; 9(1):53-62.
Score: 0.049
-
Chemoprevention of urothelial cell carcinoma growth and invasion by the dual COX-LOX inhibitor licofelone in UPII-SV40T transgenic mice. Cancer Prev Res (Phila). 2014 Jul; 7(7):708-16.
Score: 0.044
-
p53-stabilizing agent CP-31398 prevents growth and invasion of urothelial cancer of the bladder in transgenic UPII-SV40T mice. Neoplasia. 2013 Aug; 15(8):966-74.
Score: 0.042
-
Anti-inflammatory phytochemicals for chemoprevention of colon cancer. Curr Cancer Drug Targets. 2013 Jun; 13(5):542-57.
Score: 0.041
-
Naproxen inhibits spontaneous lung adenocarcinoma formation in KrasG12V mice. Neoplasia. 2021 06; 23(6):574-583.
Score: 0.018
-
Molecular Targets in Precision Chemoprevention of Colorectal Cancer: An Update from Pre-Clinical to Clinical Trials. Int J Mol Sci. 2020 Dec 17; 21(24).
Score: 0.017
-
Intermittent Dosing Regimens of Aspirin and Naproxen Inhibit Azoxymethane-Induced Colon Adenoma Progression to Adenocarcinoma and Invasive Carcinoma. Cancer Prev Res (Phila). 2019 11; 12(11):751-762.
Score: 0.016
-
Targeting cholecystokinin-2 receptor for pancreatic cancer chemoprevention. Mol Carcinog. 2019 10; 58(10):1908-1918.
Score: 0.016
-
Targeting the paracrine hormone-dependent guanylate cyclase/cGMP/phosphodiesterases signaling pathway for colorectal cancer prevention. Semin Cancer Biol. 2019 06; 56:168-174.
Score: 0.015
-
Current Challenges and Opportunities for Chemoprevention of Pancreatic Cancer. Curr Med Chem. 2018; 25(22):2535-2544.
Score: 0.014
-
Development of a dietary formulation of the SHetA2 chemoprevention drug for mice. Invest New Drugs. 2018 08; 36(4):561-570.
Score: 0.014
-
Prevention and treatment of cancers by immune modulating nutrients. Mol Nutr Food Res. 2016 06; 60(6):1275-94.
Score: 0.013
-
Simultaneous targeting of 5-LOX-COX and EGFR blocks progression of pancreatic ductal adenocarcinoma. Oncotarget. 2015 Oct 20; 6(32):33290-305.
Score: 0.012
-
Early and delayed intervention with rapamycin prevents NNK-induced lung adenocarcinoma in A/J mice. Oncol Rep. 2015 Dec; 34(6):2925-34.
Score: 0.012
-
Targeting pancreatitis blocks tumor-initiating stem cells and pancreatic cancer progression. Oncotarget. 2015 Jun 20; 6(17):15524-39.
Score: 0.012
-
Eflornithine (DFMO) prevents progression of pancreatic cancer by modulating ornithine decarboxylase signaling. Cancer Prev Res (Phila). 2014 Dec; 7(12):1198-209.
Score: 0.011
-
Evaluation of (99m)Tc-probestin SPECT as a novel technique for noninvasive imaging of kidney aminopeptidase N expression. Mol Pharm. 2014 Aug 04; 11(8):2948-53.
Score: 0.011
-
The epidermal growth factor receptor inhibitor gefitinib prevents the progression of pancreatic lesions to carcinoma in a conditional LSL-KrasG12D/+ transgenic mouse model. Cancer Prev Res (Phila). 2010 Nov; 3(11):1417-26.
Score: 0.009